Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Journal of Veterinary Science ; : 187-189, 2011.
Artigo em Inglês | WPRIM | ID: wpr-189394

RESUMO

We investigated the immunostimulatory effects of a novel beta-glucan purified from Paenibacillus (P.) polymyxa JB115 on bone marrow-derived dendritic cells (DCs), a type of potent antigen-presenting cells. beta-glucan isolated from P. polymyxa JB115 enhanced the viability and induced the maturation of DCs. beta-glucan markedly increased the cytokine production of DCs and surface expression of DC markers. In addition, DCs treated with beta-glucan showed a higher capacity to stimulate allogeneic spleen cell proliferation compared to those treated with medium alone. These results demonstrate the effect of beta-glucan on DC maturation and may increase the use of beta-glucan.


Assuntos
Animais , Camundongos , Células da Medula Óssea/citologia , Sobrevivência Celular/efeitos dos fármacos , Células Dendríticas/citologia , Citometria de Fluxo , Imunofenotipagem/métodos , Interleucina-12/análise , Camundongos Endogâmicos BALB C , Óxido Nítrico/análise , Paenibacillus/química , Fator de Necrose Tumoral alfa/análise , beta-Glucanas/isolamento & purificação
2.
Journal of Korean Medical Science ; : 1231-1237, 2011.
Artigo em Inglês | WPRIM | ID: wpr-29142

RESUMO

The purpose of this study was to investigate clinical and immunological responses to Demodex on the ocular surface. Thirteen eyes in 10 patients with Demodex blepharitis and chronic ocular surface disorders were included in this study and treated by lid scrubbing with tea tree oil for the eradication of Demodex. We evaluated ocular surface manifestations and Demodex counts, and analyzed IL-1beta, IL-5, IL-7, IL-12, IL-13, IL-17, granulocyte colony-stimulating factor, and macrophage inflammatory protein-1beta in tear samples before and after the treatment. All patients exhibited ocular surface manifestations including corneal nodular opacity, peripheral corneal vascularization, refractory corneal erosion and infiltration, or chronic conjunctival inflammatory signs before treatment. After treatment, Demodex was nearly eradicated, tear concentrations of IL-1beta and IL-17 were significantly reduced and substantial clinical improvement was observed in all patients. In conclusion, we believe that Demodex plays an aggravating role in inflammatory ocular surface disorders.


Assuntos
Adolescente , Adulto , Idoso , Animais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Ácaros e Carrapatos/efeitos dos fármacos , Blefarite/tratamento farmacológico , Quimiocina CCL4/análise , Fator Estimulador de Colônias de Granulócitos/análise , Interleucina-12/análise , Interleucina-13/análise , Interleucina-17/análise , Interleucina-1beta/análise , Interleucina-5/análise , Interleucina-7/análise , Óleo de Melaleuca/uso terapêutico , Lágrimas/metabolismo
3.
Journal of Korean Medical Science ; : 860-866, 2009.
Artigo em Inglês | WPRIM | ID: wpr-223646

RESUMO

CpG-Oligodeoxynucleotide (ODN) has two backbones. Phosphorothioate backbone (PS) shows a strong immunostimulating effect while phosphodiester (PE) shows little in vivo. 3' hexameric deoxyriboguanosine-run (3' dG6-run) conjugation to PE CpG-ODN has been reported to enhance immunostimulation and to protect against asthma when injected at the time of sensitization in mice. We evaluated the treatment effects of PE and PS CpG-ODN with or without 3' dG6-run on asthma in presensitized mice. BALB/c mice sensitized with ovalbumin and alum were challenged with 1% ovalbumin on three days. CpG-ODNs (100 microgram) or PBS were injected 4 times; 27 hr before challenge and 3 hr before each challenge (CpG-dG6: CpG-ODN with 3' dG6-run, PE*-CpG-dG6: PE-CpG-dG6 with two PS backbones at the 5' terminus). PE-CpG showed no treatment effect. PE-CpG-dG6 only increased ovalbumin-specific IgG2a. PE*-CpG-dG6 increased ovalbumin-specific IgG2a but also reduced BAL fluid eosinophils and airway hyperresponsiveness. PS-CpG increased ovalbumin-specific IgG2a, reduced airway inflammation and airway hyperresponsiveness. PS-CpG-dG6 was less effective than PS-CpG on airway inflammation and airway hyperresponsiveness. In pre-sensitized mice, PE-CpG required not only 3' dG6-run but also the modification of two PS linkages at 5' terminus to inhibit features of asthma. PS-CpG was strong enough to inhibit asthma but PS-CpG-dG6 was less effective.


Assuntos
Animais , Feminino , Camundongos , Antiasmáticos/uso terapêutico , Asma/tratamento farmacológico , Hiper-Reatividade Brônquica/tratamento farmacológico , Líquido da Lavagem Broncoalveolar/imunologia , Desoxiguanosina/análogos & derivados , Imunoglobulina G/metabolismo , Interleucina-12/análise , Interleucina-4/análise , Interleucina-5/análise , Pulmão/patologia , Camundongos Endogâmicos BALB C , Oligodesoxirribonucleotídeos/uso terapêutico , Oligonucleotídeos Fosforotioatos/uso terapêutico , Esplenomegalia/patologia
4.
Dental Journal-Shahid Beheshti University of Medical Sciences. 2009; 26 (4): 363-368
em Persa | IMEMR | ID: emr-91007

RESUMO

Chronic dental periapical lesions resulted from chronic inflammatory response to the periapical tissues. Since T-helper [CD4+Y] cells are the prominent cells in these lesions, so the aim of this study was to determine the correlation between the concentration of IL-4 and IL- 12 [most important cytokines for differentiation of T helper 2 and T helper 1 cells, respectively], and the diameter of chronic periapical lesions. Thirty-eight chronic periapical lesions were collected which 18 periapical lesions had diameter of >/= 5 millimeter [case group] and 20 periapical lesions had the diameter <5 millimeter [control group]. Tissue samples were cultured for 72 hours, then ELISA [Enzyme linked immuno-sorbent Assay] was used for determining the concentration of IL-4 and IL- 12 in supernatant fluids. Mann-whitney U and Spearman correlation tests were used to analyze the data. IL-4 and IL- 12 were found in all of samples. There was no significant difference between case and control groups regarding the concentration of IL-4, IL- 12 and IL-4/IL- 12. The only significant correlation was between IL-4 and IL-6 concentration without any regard to the diameter of lesions [P<0.001] [Spearman correlation coefficient=0.593]. It is concluded that in chronic periapical lesions, probably T helper 1 and T helper 2 cells participate in active phases of inflammation and tissue damage equally. This could be resulted from mixed population of bacteria in these lesions


Assuntos
Humanos , Interleucina-12/análise , Periodontite Periapical/imunologia , Ensaio de Imunoadsorção Enzimática
5.
Experimental & Molecular Medicine ; : 72-84, 2006.
Artigo em Inglês | WPRIM | ID: wpr-43452

RESUMO

Several myeloid leukemia-derived cells have been reported to possess the ability to differentiate into dendritic cells (DC). MUTZ-3, a myeloid leukemia cell line, responds to GM-CSF, IL-4 and TNF-alpha, and acquires a phenotype similar to immature monocyte-derived DC (MoDC). In the present study, MUTZ-3-derived DC (MuDC) showed high level expression of HLA class II molecules, CD80 and CD86, and were able to function as potent antigen presenting cells as previously reported. Interestingly, MuDC maturation was induced by CD40-mediated stimulation, but not by LPS stimulation. We analyzed CCR1, CCR7 and Toll-like receptor (TLR) expressions in MuDC, and measured IL-10 and IL-12 production after maturation stimuli. Although MuDC expressed the mRNA for TLR4, a major component of the LPS receptor system, they did not show an enhanced level of CCR7 or cytokine production after LPS stimulation. In contrast, they responded to CD40 stimulation, which resulted in increased levels of CD83, CD86 and CCR7. Moreover, while LPSstimulated MoDC could potently stimulate NK cells in a DC-NK cell co-culture, LPS-stimulated MuDC failed to stimulate primary NK cells. Taken together, our findings suggest that, although MuDC express TLR4, unlike TNF-alpha and IL-1beta, LPS does not stimulate MuDC to acquire mature phenotypes, and they may have impaired activity to initiate innate immune response.


Assuntos
Humanos , Antígenos CD40/metabolismo , Antígeno B7-1/metabolismo , Antígeno B7-2/metabolismo , Western Blotting , Ligante de CD40/metabolismo , Diferenciação Celular , Linhagem Celular Tumoral , Técnicas de Cocultura , Células Dendríticas/efeitos dos fármacos , Ensaio de Imunoadsorção Enzimática , Fluoresceína-5-Isotiocianato , Técnica Indireta de Fluorescência para Anticorpo , Corantes Fluorescentes , Interleucina-10/análise , Interleucina-12/análise , Células Matadoras Naturais/metabolismo , Leucemia Mieloide/patologia , Lipopolissacarídeos/farmacologia , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Receptor 4 Toll-Like/metabolismo , Fator de Necrose Tumoral alfa/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
6.
The Korean Journal of Parasitology ; : 55-61, 2006.
Artigo em Inglês | WPRIM | ID: wpr-60515

RESUMO

For treating Leishmania major infection in BALB/c mice, we used thalidomide in conjunction with glucantime. Groups of mice were challenged with 5 x 10(3) metacyclic promastigotes of L. major subcutaneously. A week after the challenge, drug treatment was started and continued for 12 days. Thalidomide was orally administrated 30 mg/kg/day and glucantime was administrated intraperitoneally (200 mg/kg/day). It was shown that the combined therapy is more effective than single therapies with each one of the drugs since the foot pad swelling in the group of mice received thalidomide and glucantime was significantly decreased (0.9 +/- 0.2 mm) compared to mice treated with either glucantime, thalidomide, or carrier alone (1.2 +/- 0.25, 1.4 +/- 0.3, and 1.7 +/- 0.27 mm, respectively). Cytokine study showed that the effect of thalidomide was not dependent on IL-12; however, it up-regulated IFN-gamma and down-regulated IL-10 production. Conclusively, thalidomide seems promising as a conjunctive therapy with antimony in murine model of visceral leishmaniasis.


Assuntos
Camundongos , Feminino , Animais , Fatores de Tempo , Talidomida/farmacologia , Compostos Organometálicos/farmacologia , Camundongos Endogâmicos BALB C , Meglumina/farmacologia , Leishmaniose Visceral/tratamento farmacológico , Leishmania major/efeitos dos fármacos , Interleucina-12/análise , Interleucina-10/análise , Interferon gama/análise , Imunossupressores/farmacologia , Quimioterapia Combinada , Progressão da Doença , Modelos Animais de Doenças , Células Cultivadas , Antiprotozoários/farmacologia
7.
Medicina (B.Aires) ; 62(2): 154-8, 2002.
Artigo em Espanhol | LILACS, BINACIS | ID: biblio-1165112

RESUMO

Several factors are involved in the selective activation of T helper 1 or T helper 2 cells, such as the type of antigen-presenting cells involved in the immune response and the different physical characteristics of antigens. The aim of this work was to evaluate if adding other antigens to tetanus toxoid modifies the original immune response. BALB/c mice were immunized with tetanus and diphtheria toxoids associated with whole-cell Bordetella pertussis (DTPw vaccine), B. pertussis soluble antigens (DTPa vaccine) or Salmonella typhi plus DTPa (DTPaSt vaccine). DTPw and DTPaSt immunization induced a T helper 1/T helper 2 (Th1/Th2) anti-tetanus response with gamma interferon and interleukin 5 production. DTPa immunization induced a Th2 response with production of interleukin 5 and interleukin 6. Only DTPw vaccine induced higher levels of IL-12 in non-immunized mice. Our findings indicate that the co-injection of whole-cell antigens such as B. pertussis or S. typhi, modifies the anti-tetanus response shifting it from Th2 to Th1 type. However, the original Th2 immune response is not modified when the vaccine consists only of soluble antigens.


Assuntos
Animais , Coelhos , Vacina contra Difteria, Tétano e Coqueluche/imunologia , Interleucina-5/biossíntese , Interleucina-6/biossíntese , Interferon gama/biossíntese , Interleucina-12/biossíntese , Baço/citologia , Baço/imunologia , Ensaio de Imunoadsorção Enzimática , Interleucina-5/análise , Interleucina-6/análise , Interferon gama/análise , Vacinas Combinadas , Interleucina-12/análise , Relação Dose-Resposta Imunológica , Camundongos Endogâmicos BALB C , Antígenos de Bactérias/administração & dosagem , Antígenos de Bactérias/imunologia
8.
Journal of Korean Medical Science ; : 217-223, 2000.
Artigo em Inglês | WPRIM | ID: wpr-18567

RESUMO

Due to their high immunostimulatory ability as well as the critical role they play in the maintenance of self-tolerance, dendritic cells have been implicated in the pathogenesis of autoimmune diseases. The non-obese diabetic (NOD) mouse is an animal model of autoimmune type 1 diabetes, in which pancreatic beta cells are selectively destroyed mainly by T cell-mediated immune responses. To elucidate initiation mechanisms of beta cell-specific autoimmunity, we attempted to generate bone marrow-derived dendritic cells from NOD mice. However, our results showed low proliferative response of NOD bone marrow cells and some defects in the differentiation into the myeloid dendritic cells. NOD dendritic cells showed lower expressions of MHC class II, B7-1, B7-2 and CD40, compared with C57BL/6 dendritic cells. In mixed lymphocyte reactions, stimulatory activities of NOD dendritic cells were also weak. Treatment with LPS, INF-gamma and anti-CD40 stimulated NOD dendritic cells to produce IL-12p70. The amount of IL-12, however, appeared to be lower than that of C57BL/6. Results of the present study indicated that there may be some defects in the development of NOD dendritic cells in the bone marrow, which might have an impact on the breakdown of self tolerance.


Assuntos
Camundongos , Animais , Doenças Autoimunes/patologia , Doenças Autoimunes/imunologia , Células da Medula Óssea/patologia , Células da Medula Óssea/imunologia , Células da Medula Óssea/química , Diferenciação Celular/imunologia , Diferenciação Celular/efeitos dos fármacos , Células Dendríticas/patologia , Células Dendríticas/imunologia , Células Dendríticas/química , Diabetes Mellitus Tipo 1/patologia , Diabetes Mellitus Tipo 1/imunologia , Ensaio de Imunoadsorção Enzimática , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Interleucina-12/análise , Interleucina-4/farmacologia , Lipopolissacarídeos/farmacologia , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos NOD , Obesidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA